Hormonal
In the context of dietary obesity, activation of Hif1α in visceral white adipocytes suppresses fatty acid oxidation and energy expenditure by transcriptionally repressing Sirt2, thereby maintaining obesity and associated metabolic pathologies.
This research highlights that in states of severe obesity, visceral fat tissue can become hypoxic, triggering biological mechanisms (Hif1a/Sirt2) that actively suppress fat burning and maintain fat stores. This suggests that for some individuals, obesity is not just a passive accumulation of energy but an active biological state that may require addressing underlying tissue health or hypoxia, rather than just caloric restriction alone.
Here we report that, in mice, Hif1a activation in visceral white adipocytes is critical to maintain dietary obesity and associated pathologies... This function of Hif1a is linked to its capacity to suppress b-oxidation, in part, through transcriptional repression of sirtuin 2 (Sirt2) NAD+-dependent deacetylase.
Why this rating
High-quality mechanistic evidence using genetically modified mouse models (adipocyte-specific knockout) and human tissue correlation, though not a human clinical trial.
Source
Dietary obesity-associated Hif1α activation in adipocytes restricts fatty acid oxidation and energy expenditure via suppression of the Sirt2-NAD<sup>+</sup> system
Jaya Krishnan et al. · Genes & Development · 2012
DOI 10.1101/gad.180406.111
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →